Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 2/2015

01-04-2015 | Letter to Editor

Hybrid Odontogenic Tumors: A Controversy

Authors: Sheetal Korde Choudhari, Amol R. Gadbail

Published in: Pathology & Oncology Research | Issue 2/2015

Login to get access

Excerpt

Tumors of oral cavity are pathologically and biologically diverse group of lesions. Odontogenic tumors presenting as a combination of established entities are reported in literature. Such an occurrence can be collision or combined/hybrid odontogenic tumor. In collision tumor, two tumors of different histogenetic source (or different topographical area) develop simultaneously and then they meet in border zone [1]. The term Hybrid tumor was first used for salivary gland tumors [2]. A hybrid tumor of odontogenic apparatus is a lesion showing combined histopathological characteristics of two or more previously recognized odontogenic tumors and\ or cysts of different categories [3]. Unlike collision tumor, tumor entities in a hybrid tumor are not separated but have an identical origin within the same topographical area. …
Literature
1.
Meyer R (1919) Beitrag zur verstaninbung uber dieNamengebung in der geschwulstlehrle. Zentralbl Pathol 30:391–6
2.
Seifert G, Donath K (1996) Hybrid tumours of salivary glands. Definition and classification of five rare cases. Eur J Cancer B Oral Oncol 32B:251–9CrossRefPubMed
3.
Ide F, Horie N, Shimoyama T, Sakashita H, Kusama K (2001) So called hybrid odontogenic tumors: do they really exist. Oral Med Pathol 6:13–21CrossRef
4.
Takeda Y, Kudo K (1986) Adenomatoid odontogenic tumor associated with calcifying odontogenic tumor. Int J Oral Maxillofac Surg 15:469–73CrossRefPubMed
5.
Seim P, Regezi JA, O’Ryan F (2005) Hybrid ameloblastoma and calcifying epithelial odontogenic tumor: case report. J Oral Maxillofac Surg 63(6):852–5CrossRefPubMed
6.
Economopoulou P, Soliriadou S (1998) An unusual tumor of the mandible with features of unicystic ameloblastoma and ameloblastic fibroma. J Oral Maxillofac Surg 56:1196–1200CrossRefPubMed
7.
Hisatomi M, Asaumi J, Konouchi H, Yanagi Y, Kishi K (2000) A case of glandular odontogenic cyst associated with ameloblastoma: correlation of diagnostic imaging with histopathological features. Dentomaxillofacial Radiol 29:249–253CrossRef
8.
Slabbert H, Altini M, Crooks J, Uys P (1992) Ameloblastoma with dentinoid induction: dentinoameloblastoma. J Oral Pathol Med 74:776–9CrossRef
9.
Allen CM, Neville BW, Hammond HL (1998) Adenomatoid dentinoma. report of four cases of an unusual odontogenic lesion. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86:313–7CrossRefPubMed
10.
Hg KH, Siar CH (2003) Odontogenic keratocyst with dentinoid formation. Oral Surg Oral Med Oral Pathol 95:601–6CrossRef
11.
Miyauchi M, Ogawa I, Takata T, Ito H, Nikai H, Ijuhhin N, Tanimoto K (1998) Itoh Y (1998) Clear cell odontogenic tumor: a case with induction of dentin like structures? J Oral Pathol Med 27:220–4
Metadata
Title
Hybrid Odontogenic Tumors: A Controversy
Authors
Sheetal Korde Choudhari
Amol R. Gadbail
Publication date
01-04-2015
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 2/2015
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-014-9844-0

Other articles of this Issue 2/2015

Pathology & Oncology Research 2/2015 Go to the issue

Letter to Editor

Pericardial Tamponade Caused by Tumor Hemorrhage – a Rare Complication of Metastatic Testicular Choriocarcinoma

Research

Overexpression of Wild-Type p53-Induced Phosphatase 1 Confers Poor Prognosis of Patients with Nasopharyngeal Carcinoma

Research

Identification of Differently Expressed Genes with Specific SNP Loci for Breast Cancer by the Integration of SNP and Gene Expression Profiling Analyses

Research

CXCR7 and CXCR4 Expressions in Infiltrative Astrocytomas and Their Interactions with HIF1α Expression and IDH1 Mutation

Research

Apoptotic Effects of Quercitrin on DLD-1 Colon Cancer Cell Line

Research

Tumor Necrosis Factor Alpha (−238 / −308) and TNFRII-VNTR (−322) Polymorphisms as Genetic Biomarkers of Susceptibility to Develop Cervical Cancer Among Tunisians
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits